These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12580645)

  • 1. Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA).
    Brown EG
    Drug Saf; 2003; 26(3):145-58. PubMed ID: 12580645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions.
    Bousquet C; Lagier G; Lillo-Le Louët A; Le Beller C; Venot A; Jaulent MC
    Drug Saf; 2005; 28(1):19-34. PubMed ID: 15649103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART.
    Brown EG
    Drug Saf; 2002; 25(6):445-52. PubMed ID: 12071782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.
    Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R
    J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MedDRA and pharmacovigilance: a complex and little-evaluated tool.
    Prescrire Int; 2016 Oct; 25(175):247-250. PubMed ID: 30645835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OntoADR a semantic resource describing adverse drug reactions to support searching, coding, and information retrieval.
    Souvignet J; Declerck G; Asfari H; Jaulent MC; Bousquet C
    J Biomed Inform; 2016 Oct; 63():100-107. PubMed ID: 27369567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using MedDRA: implications for risk management.
    Brown EG
    Drug Saf; 2004; 27(8):591-602. PubMed ID: 15154830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The medical dictionary for regulatory activities (MedDRA).
    Brown EG; Wood L; Wood S
    Drug Saf; 1999 Feb; 20(2):109-17. PubMed ID: 10082069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM).
    Yokotsuka M; Aoyama M; Kubota K
    Int J Med Inform; 2000 Jul; 57(2-3):139-53. PubMed ID: 10961570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social Media Listening for Routine Post-Marketing Safety Surveillance.
    Powell GE; Seifert HA; Reblin T; Burstein PJ; Blowers J; Menius JA; Painter JL; Thomas M; Pierce CE; Rodriguez HW; Brownstein JS; Freifeld CC; Bell HG; Dasgupta N
    Drug Saf; 2016 May; 39(5):443-54. PubMed ID: 26798054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
    Wu L; Ingle T; Liu Z; Zhao-Wong A; Harris S; Thakkar S; Zhou G; Yang J; Xu J; Mehta D; Ge W; Tong W; Fang H
    BMC Bioinformatics; 2019 Mar; 20(Suppl 2):97. PubMed ID: 30871458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MedDRA paradox.
    Merrill GH
    AMIA Annu Symp Proc; 2008 Nov; 2008():470-4. PubMed ID: 18998828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental investigation of masking in the US FDA adverse event reporting system database.
    Wang HW; Hochberg AM; Pearson RK; Hauben M
    Drug Saf; 2010 Dec; 33(12):1117-33. PubMed ID: 21077702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience using MedDRA for global events coding in HIV clinical trials.
    Tonéatti C; Saïdi Y; Meiffrédy V; Tangre P; Harel M; Eliette V; Dormont J; Pierre Aboulker J
    Contemp Clin Trials; 2006 Feb; 27(1):13-22. PubMed ID: 16288902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. About the necessity to manage events coded with MedDRA prior to statistical analysis: proposal of a strategy with application to a randomized clinical trial, ANRS 099 ALIZE.
    Journot V; Tabuteau S; Collin F; Molina JM; Chene G; Rancinan C;
    Contemp Clin Trials; 2008 Mar; 29(2):95-101. PubMed ID: 17613282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semantic distance-based creation of clusters of pharmacovigilance terms and their evaluation.
    Dupuch M; Grabar N
    J Biomed Inform; 2015 Apr; 54():174-85. PubMed ID: 25659451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validating a Framework for Coding Patient-Reported Health Information to the Medical Dictionary for Regulatory Activities Terminology: An Evaluative Study.
    Brajovic S; Blaser DA; Zisk M; Caligtan C; Okun S; Hall M; Pamer CA
    JMIR Med Inform; 2018 Aug; 6(3):e42. PubMed ID: 30131314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tabulation and analysis of pharmacovigilance data using the medical dictionary for regulatory activities.
    Brown Bmedsci Mb Chb Mrcgp Ffpm E; Douglas Bsc S
    Pharmacoepidemiol Drug Saf; 2000 Nov; 9(6):479-89. PubMed ID: 19025854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardised MedDRA queries: their role in signal detection.
    Mozzicato P
    Drug Saf; 2007; 30(7):617-9. PubMed ID: 17604415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.